For instance, perinuclear-localized STING in ER+ breast cancers has been demonstrated to be an independent predictor of favorable prognosis, associated with higher immune cell infiltration and upregulation of immune checkpoints15. The gene discussed is STING1; the disease is breast carcinoma.